Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

10 May 2010 07:00

RNS Number : 5791L
Tarsus Group PLC
10 May 2010
 



 

 

 

TARSUS GROUP plc

 

Interim Management Statement

 

Tarsus Group Plc ("Tarsus" or "the Group"), the international business-to-business media group, is today publishing its Interim Management Statement relating to the period from the publication of its Preliminary Results on 8 March 2010 to 9 May 2010.

 

Trading Performance

 

Trading for the period has been in line with the Board's expectations. A summary of major developments includes:

 

§ US - continued recovery & momentum

 

The Medical division continues to gain momentum. The April Orlando event produced revenues well ahead of last year, driven by very strong growth from its education programmes. Exhibition and conference revenues also grew for the first time in 18 months.

 

§ France - management action retains margins within expectations

 

A number of small exhibitions have taken place in France since 8 March. As expected, the declining revenue trends experienced in the second half of 2009 have continued into the first half of 2010. Strong cost management has resulted in margins remaining within our expectations.

 

§ Emerging Markets

 

No material events have taken place since 8 March.

 

Financial Position

 

There have been no significant changes to the financial position of the Group since the publication of the Preliminary Results on 8 March 2010.

 

Outlook

 

At our preliminary results at the start of March we announced the launch of "Project 50/13" to accelerate our scale in Emerging Markets. Our business infrastructure in the region is now established and Tarsus has a much improved platform within Asia and the Middle East from which to continue to drive strong growth.

 

As in previous years, the Group's revenues remain heavily second-half weighted and, overall, forward bookings remain at a similar level to 2009.

 

The French portfolio is weighted towards the 4th quarter of the year and we are now seeing signs of stabilisation in that market, with forward bookings for 4th quarter events at similar levels to last year. Given the current economic outlook for Europe, we continue to remain cautious.

 

US sales are strong and ahead of 2009, driven mainly by our Off-Price (discount clothing) and Medical divisions. Labelexpo America's sales are marginally behind the previous edition, owing to smaller exhibitors booking later in the cycle.

 

In the Emerging Markets division, the Group's largest event this year is MEBA (business aviation) which takes place in Dubai for which forward bookings are well ahead of the previous cycle.

 

Our view of trading for 2010 is unchanged with long term exhibition trends intact. The recovery in the US economy is benefiting our business in that market and we are seeing good growth prospects and opportunities in Emerging Markets. Our strong brands, diversified portfolio of market leading events and increased focus on Emerging Markets leave Tarsus well positioned for the future.

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

 

Media:

 

Madano Partnership

Matthew Moth 020 7593 4000

 

Investors/Analysts:

 

IRfocus

Neville Harris 020 7593 4015

 

Scott Harris

Stephen Scott, Jeremy Wiseman 020 7653 0030

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKKODKABKDOPK
Date   Source Headline
24th Sep 20077:02 amRNSAcquisition
5th Sep 20077:00 amRNSInterim Results
5th Sep 20077:00 amRNSAcquisition
24th Jul 20078:18 amRNSCapRegen First Day of Dealing
12th Jul 20077:00 amRNSAcquisition
2nd Jul 20077:00 amRNSTrading Statement
2nd Jul 20077:00 amRNSTrading Statement
29th Jun 20072:29 pmRNSAdditional Listing
26th Jun 20072:24 pmRNSLaunch & Float of CapRegen
24th May 200711:47 amRNSDirector/PDMR Shareholding
18th May 20074:20 pmRNSHolding(s) in Company
11th May 20073:18 pmRNSDirShrHolding & Add Listing
2nd May 20075:33 pmRNSAdditional Listing
30th Apr 20072:32 pmRNSDirector/PDMR Shareholding
20th Apr 20072:53 pmRNSHolding(s) in Company
20th Apr 20072:50 pmRNSTVR & Director Shareholding
18th Apr 20074:59 pmRNSResult of AGM
18th Apr 20077:00 amRNSAGM Statement
30th Mar 20074:05 pmRNSTotal Voting Rights
28th Mar 200712:45 pmRNSHolding(s) in Company
28th Mar 200712:43 pmRNSHolding(s) in Company
22nd Mar 20076:26 pmRNSDocument submissions
20th Mar 20072:08 pmRNSHolding(s) in Company
20th Mar 20071:50 pmRNSHolding(s) in Company
16th Mar 20074:57 pmRNSAdditional Listing
14th Mar 20075:13 pmRNSPDMR Options
9th Mar 20075:26 pmRNSHolding(s) in Company
8th Mar 20074:52 pmRNSPDMR Option Excercise
8th Mar 20074:49 pmRNSAnnual Information Update
7th Mar 200711:57 amRNSHolding(s) in Company
1st Mar 20077:03 amRNSFinal Results
14th Feb 20077:00 amRNSChinese Partnership
26th Jan 20075:15 pmRNSHolding(s) in Company
23rd Jan 20077:00 amRNSNotice of Results
4th Jan 20077:01 amRNSDirectorate Change
4th Jan 20077:00 amRNSTrading Statement
18th Dec 200610:21 amRNSAdditional Listing
15th Dec 20065:33 pmRNSTotal Voting Rights
23rd Nov 200611:02 amRNSHolding(s) in Company
16th Nov 20067:02 amRNSAcquisition & Vendor Placing
2nd Nov 200611:29 amRNSChinese Business Presentation
1st Nov 20067:00 amRNSAdditional Listing
3rd Oct 20067:00 amRNSAcquisition
26th Sep 20064:14 pmRNSScrip Dividend Circular
19th Sep 200610:51 amRNSDirector/PDMR Shareholding
4th Sep 20067:02 amRNSInterim Results
31st Aug 20067:00 amRNSNotice of Results
4th Jul 20065:29 pmRNSDirector/PDMR Shareholding
4th Jul 20067:00 amRNSTrading Statement
24th Apr 20062:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.